PNC Financial Services Group’s Nautilus Biotechnolgy NAUT Stock Holding History
Bought
Maintained
Sold
Other funds holding NAUT
ACM
PA
CM
MVG
CFM
ACI
CGL
TM
PNC Financial Services Group's NAUT Position: Q2 2025 in Review
PNC Financial Services Group sold out of Nautilus Biotechnolgy (NAUT) in Q2 2025, closing a stake of 3,966 shares — an estimated $3.42K sold.
PNC Financial Services Group first reported a position in NAUT in Q4 2021 and held it in 10 quarters. The position peaked at $16K in Q4 2021. 71 funds tracked by Wall St. Rank hold NAUT as of Q2 2025.
- PNC Financial Services Group reported no remaining Nautilus Biotechnolgy position as of Q2 2025 after selling out during the quarter.
- PNC Financial Services Group sold 3,966 Nautilus Biotechnolgy shares in Q2 2025, an estimated $3.42K.
- PNC Financial Services Group first reported a position in Nautilus Biotechnolgy in Q4 2021 and held it in 10 quarters.
- PNC Financial Services Group's Nautilus Biotechnolgy position peaked at $16K in Q4 2021.
- 71 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q2 2025.
Based on PNC Financial Services Group's 13F filing for Q2 2025, filed 8 Aug 2025.